secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2025-10-24T23:59:59+00:00
Accession:  0001746473-25-000159
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics CBO Hans Hull resigns effective October 20, 2025
--------------------------------------------------------------------

- Hans Hull resigned as Chief Business Officer, effective October 20, 2025.
- Resignation was not due to any disagreement on operations, policies, or practices.
- No replacement has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647325000159/0001746473-25-000159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647325000159/plrx-20251020.htm
  HTML page:      https://secwatch.observer/filing/0001746473-25-000159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer